No image

Mycoplasma pneumoniae Negative Control

Details

Device typeMycoplasma pneumoniae immunoglobulin G (IgG) antibody IVD, control: A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to Mycoplasma pneumoniae bacteria in a clinical specimen.

FDA categoryDna-Reagents, Mycoplasma Spp.

Device IDB110MPN12100

Catalog numberMPN-1210

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone847-544-5044

Emailbion@mblintl.com

Related products

Product	Model	Company	Device type
EBV Negative ControlBion Enterprises, Ltd.Epstein-Barr virus (EBV) immunoglobulin G (IgG) antibody IVD, control	EBN-5010	Bion Enterprises, Ltd.	Epstein-Barr virus (EBV) immunoglobulin G (IgG) antibody IVD, control
Influenza B Negative ControlBion Enterprises, Ltd.Influenza B virus immunoglobulin G (IgG) antibody IVD, control	IBN-2110	Bion Enterprises, Ltd.	Influenza B virus immunoglobulin G (IgG) antibody IVD, control
Influenza A Negative ControlBion Enterprises, Ltd.Influenza A virus immunoglobulin G (IgG) antibody IVD, control	IAN-1110	Bion Enterprises, Ltd.	Influenza A virus immunoglobulin G (IgG) antibody IVD, control
CMV IgG ControlBion Enterprises, Ltd.Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control	CMG-2020	Bion Enterprises, Ltd.	Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control

Product	Model	Company	Device type